Flexcin International, Inc. Revs Up New Flexcin Website to Help Adults Suffering With Arthritis and Other Joint Diseases
New site is more user-friendly for customers of alternative, all-natural product Flexcin, which continues its success in relieving many forms of joint pain.
Fort Myers, Florida (PRWEB) December 05, 2013
Flexcin International, Inc., the makers of all-natural health products including Flexcin with CM8®, a joint nutritional product that helps to alleviate the pain and stiffness associated with diseases like Arthritis and Fibromyalgia, launched a new website for Flexcin.
The new website http://www.flexcin.com gives customers a more user friendly site with enhanced features and additional product options.
According to the CDC in their July 2013 report, Arthritis is the nation’s most common cause of disability. It limits the activities of 21 million Americans—for example, preventing them from being able to climb stairs or walk more than short distances. For 1 of 3 adults of working age (18–65 years) with arthritis, it can limit the type or amount of work they do or whether they can work at all. This number is expected to increase sharply as the U. S. population continues to age. Arthritis includes more than 100 different rheumatic diseases and conditions, the most common of which is osteoarthritis. Other forms of arthritis that occur often are rheumatoid arthritis, lupus, fibromyalgia, and gout.
“Today, we also receives plenty of inquiries from active Baby Boomers who feel more aches and joint discomfort as a result of active lifestyles,” said Tamer Elsafy, CEO and founder of Flexcin. Our new website will help them to get started with Flexcin and save money.”
About Flexcin International
Flexcin International, Inc. is a manufacturer and marketer of leading natural supplements that promote optimal joint health. Along with its FlexPet line of pet joint supplements, Flexcin products are the only degenerative joint relief supplements with the CM8® ingredient to stimulate joint fluid lubrication, strengthen cartilage and increase overall mobility.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/11/prweb11295998.htm